Abstract:Purpose: This study aimed to investigate the abnormal infiltration of immune cells in type 1 diabetes mellitus (T1D) and elucidate their regulatory mechanisms. Methods: Public T1D-related gene expression data were obtained from the Gene Expression Omnibus database.The GSE123658 dataset analyzed whole blood RNA-seq data from type 1 diabetic patients and healthy volunteers. The GSE110914 dataset analyzed neutrophils purified from peripheral blood of patients with symptomatic and pre-symptomatic type 1 diabetes (T1D), at risk of T1D, and healthy controls. Immune cell infiltration analysis was performed to identify abnormally infiltrating immune cells. Differentially expressed immune genes (DEIGs) in T1D samples were identified, followed by the construction of an immune gene signature (IGS) using a protein-protein interaction (PPI) network and Least absolute shrinkage and selection operator Cox regression analyses (LASSO Cox regression analyses). The regulatory mechanisms underlying IGS were explored using gene set enrichment analysis. Furthermore, expression validation, diagnostic efficacy evaluation, and upstream miRNA prediction of hub signature genes were performed. We verified the miRNA expression of the key gene colony stimulating factor 1 (CSF1) and microRNA-326 (miR-326) by reverse transcription-quantitative PCR (RT‒qPCR). Results: The proportion of infiltrating T and natural killer (NK) cells differed between the T1D and control samples, and 207 immune genes (IGs) related to these immune cells were extracted. After differential expression, PPI, and LASSO Cox regression analyses, four signature DEIGs were identified for IGS construction: notch receptor 1 (NOTCH1), Janus kinase 3 (JAK3), tumor necrosis factor receptor superfamily member 4(TNFRSF4), and CSF1. Key pathways such as the Toll-like receptor signaling pathway were significantly activated in the high-risk group. Moreover, the upregulation of CSF1 in T1D samples was confirmed using a validation dataset, and CSF1 showed high diagnostic efficacy for T1D. Furthermore, CSF1 was targeted by miR-326.We used validated key genes in T1D patients, several of which were confirmed by RT‒qPCR. Conclusion: In conclusion, the identified key IGs may play an important role in T1D. CSF1 can be developed as a novel diagnostic biomarker for T1D.

Decreased Mir-146 Expression in Peripheral Blood Mononuclear Cells is Correlated with Ongoing Islet Autoimmunity in Type 1 Diabetes Patients

Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes

Role of Decreased Expression of Mir-155 and Mir-146A in Peripheral Blood of Type 2 Diabetes Mellitus Patients with Diabetic Peripheral Neuropathy

miRNA-Mediated Immune Regulation in Islet Autoimmunity and Type 1 Diabetes

Identification of monocyte-related transcriptomic signature of peripheral blood mononuclear cells in type 1 diabetes

Mir-192 Is Upregulated In T1dm, Regulates Pancreatic -Cell Development And Inhibits Insulin Secretion Through Suppressing Glp-1 Expression

Increased MicroRNA-146a Levels in Plasma of Patients with Newly Diagnosed Type 2 Diabetes Mellitus

miRNA Regulation of T Cells in Islet Autoimmunity and Type 1 Diabetes

MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections

Peripheral Blood Mononuclear Cells from Patients with Type 1 Diabetes and Diabetic Retinopathy Produce Higher Levels of IL-17A, IL-10 and IL-6 and Lower Levels of IFN-γ—A Pilot Study

Two Novel MicroRNA Biomarkers Related to Β-Cell Damage and Their Potential Values for Early Diagnosis of Type 1 Diabetes

1260-P: Gut Microbiome and Metabolic Activity in Type 1 Diabetes—An Analysis Based on the Presence of GADA

Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic Β- and Α-Cells

Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes

Identification of Key Genes and Pathways in Peripheral Blood Mononuclear Cells of Type 1 Diabetes Mellitus by Integrated Bioinformatics Analysis

Systematic Profiling Of Mrna And Mirna Expression In The Pancreatic Islets Of Spontaneously Diabetic Goto-Kakizaki Rats

Association of MicroRNA-146a with Type 1 and 2 Diabetes and their Related Complications

MicroRNA Networks in Pancreatic Islet Cells: Normal Function and Type 2 Diabetes

Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That Mir-25 Associates to Residual Beta-Cell Function and Glycaemic Control During Disease Progression

Identification of Immune Gene Signature Associated with T Cells and Natural Killer Cells in Type 1 Diabetes

Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature